FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

19338005: 2 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    32597014 Two en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442102012 2 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442103019 2 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    2 Is a General adjectival modifier false Inferred relationship Some
    2 Is a Number false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely hydrocodone bitartrate 500 microgram/1 milliliter and paracetamol 33.3 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Adrenaline (as adrenaline acid tartrate) 5 mg/mL and guanethidine 10 mg/mL eye solution Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and etidocaine hydrochloride 15 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely epinephrine 10 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely fluconazole 2 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely morphine sulfate 2 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely epinephrine 2 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely epinephrine 2 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and lidocaine hydrochloride 5 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely hypromellose 2 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely epinephrine 12.5 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Adrenaline 10 microgram/mL and mepivacaine hydrochloride 20 mg/mL solution for injection Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely cefotaxime sodium 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False 2 Inferred relationship Some 1
    Paracetamol 650 mg and pentazocine 25 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Clemastine fumarate 670 microgram and phenylpropanolamine 25 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely budesonide 160 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely budesonide 80 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Chlorpromazine hydrochloride 2 mg/mL oral solution Has concentration strength numerator value False 2 Inferred relationship Some 1
    Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and prilocaine hydrochloride 40 mg/mL solution for injection Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely glucose 100 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Corbadrine 50 microgram/mL and mepivacaine hydrochloride 30 mg/mL solution for injection Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely hydrocortisone 2 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely cocaine (as cocaine hydrochloride) 50 milligram/1 milliliter and epinephrine 200 microgram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely brimonidine tartrate 2 milligram/1 milliliter and timolol 5 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Dextromethorphan hydrobromide 60 mg and guaifenesin 1.2 g prolonged-release oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Benserazide 12.5 mg and levodopa 50 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely dextromethorphan hydrobromide 30 milligram and guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely salbutamol (as salbutamol sulfate) 2 milligram/1 milliliter conventional release solution for inhalation (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Some 1
    Neomycin and prednisolone only product in ocular dose form Count of base of active ingredient False 2 Inferred relationship Some
    Betamethasone and neomycin only product in otic dose form Count of base of active ingredient False 2 Inferred relationship Some
    Betamethasone and neomycin only product in nasal dose form Count of base of active ingredient False 2 Inferred relationship Some
    Hydrocortisone and neomycin only product in otic dose form Count of base of active ingredient False 2 Inferred relationship Some
    Product containing only hydrocortisone and neomycin in ocular dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing only neomycin and prednisolone in otic dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Some
    Acetic acid and oxyquinoline only product in vaginal dose form Count of base of active ingredient False 2 Inferred relationship Some
    Acetic acid and oxyquinoline only product Count of base of active ingredient False 2 Inferred relationship Some
    Menthol 30 microgram/mg and methyl salicylate 100 microgram/mg cutaneous patch Count of base of active ingredient False 2 Inferred relationship Some
    Cefoperazone (as cefoperazone sodium) 2 g powder for solution for injection vial Has presentation strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely amoxicillin anhydrous (as amoxicillin) 40 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 5.7 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely amoxicillin anhydrous (as amoxicillin) 400 milligram and clavulanic acid (as clavulanate potassium) 57 milligram/1 each conventional release chewable tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem anhydrous (as imipenem) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Ceftizoxime (as ceftizoxime sodium) 2 g powder for solution for injection vial Has presentation strength numerator value False 2 Inferred relationship Some 1
    Piperacillin anhydrous (as piperacillin sodium) 2 g powder for solution for injection vial Has presentation strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oral spray (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely cannabinol 25 milligram/1 milliliter and tetrahydrocannabinol 27 milligram/1 milliliter conventional release oral spray (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely cefamandole (as cefamandole nafate) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False 2 Inferred relationship Some 1
    Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet Count of base of active ingredient False 2 Inferred relationship Some
    Pituitary follicle stimulating hormone 150 unit and pituitary luteinizing hormone 150 unit powder for solution for injection vial Count of base of active ingredient False 2 Inferred relationship Some
    Lidocaine 25 mg/mL and prilocaine 25 mg/mL dental gel Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely amoxicillin anhydrous (as amoxicillin) 200 milligram and clavulanic acid (as clavulanate potassium) 28.5 milligram/1 each conventional release chewable tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Coagulation factor VIII 1000 unit and von Willebrand factor 2500 unit powder for solution for injection vial Count of base of active ingredient False 2 Inferred relationship Some
    Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely amoxicillin anhydrous (as amoxicillin) 250 milligram and clavulanic acid (as clavulanate potassium) 62.5 milligram/1 each conventional release chewable tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Cefmetazole (as cefmetazole sodium) 2 g powder for solution for injection vial Has presentation strength numerator value False 2 Inferred relationship Some 1
    Adrenaline 1 microgram/mg and lidocaine hydrochloride 100 microgram/mg cutaneous patch Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely amoxicillin anhydrous (as amoxicillin) 120 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 8.58 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Coagulation factor VIII 500 unit and von Willebrand factor 1250 unit powder for solution for injection vial Count of base of active ingredient False 2 Inferred relationship Some
    Mezlocillin (as mezlocillin sodium) 2 g powder for solution for injection vial Has presentation strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely clavulanic acid (as clavulanate potassium) 1 milligram and ticarcillin (as ticarcillin disodium) 30 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely coal tar 25 milligram/1 milliliter and lecithin 3 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely salicylic acid 30 milligram/1 milliliter and sulfur 50 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution Count of base of active ingredient False 2 Inferred relationship Some
    Mequinol and tretinoin only product in cutaneous dose form Count of base of active ingredient False 2 Inferred relationship Some
    Product containing only aspirin and glycine in oromucosal dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Some
    Loteprednol and tobramycin only product in ocular dose form Count of base of active ingredient False 2 Inferred relationship Some
    Calcium phosphate and carmellose only product in parenteral dose form Count of base of active ingredient False 2 Inferred relationship Some
    Ciprofloxacin and dexamethasone only product in otic dose form Count of base of active ingredient False 2 Inferred relationship Some
    Product containing only dextromethorphan and guaifenesin in oral dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Some
    Dextromethorphan and promethazine only product in oral dose form Count of base of active ingredient False 2 Inferred relationship Some
    Fenoterol and ipratropium only product in pulmonary dose form Count of base of active ingredient False 2 Inferred relationship Some
    Product containing only fluorescein stain and proxymetacaine in ocular dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Some
    Frangula and Sterculia gum only product in oral dose form Count of base of active ingredient False 2 Inferred relationship Some
    Fluorometholone and tobramycin only product in ocular dose form Count of base of active ingredient False 2 Inferred relationship Some
    Product containing only cinchocaine and prednisolone in rectal dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Some
    Diiodohydroxyquinoline and hydrocortisone only product in cutaneous dose form Count of base of active ingredient False 2 Inferred relationship Some
    Product containing only ampicillin and sulbactam in parenteral dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Some
    Salicylic acid and zinc oxide only product in cutaneous dose form Count of base of active ingredient False 2 Inferred relationship Some
    Product containing only diphenhydramine and zinc acetate in cutaneous dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Some
    Betamethasone and calcipotriol only product in cutaneous dose form Count of base of active ingredient False 2 Inferred relationship Some
    Product containing only mucin and xylitol in oromucosal dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Some
    Naphazoline and pheniramine only product in ocular dose form Count of base of active ingredient False 2 Inferred relationship Some
    Product containing only clindamycin and tretinoin in cutaneous dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Some
    Acetic acid and hydrocortisone only product in otic dose form Count of base of active ingredient False 2 Inferred relationship Some
    Brimonidine and timolol only product in ocular dose form Count of base of active ingredient False 2 Inferred relationship Some
    Coal tar and lecithin only product in cutaneous dose form Count of base of active ingredient False 2 Inferred relationship Some
    Product containing only sodium benzoate and sodium phenylacetate in parenteral dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing only bromazine and codeine in oral dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Some
    Nicotinic acid and simvastatin only product in oral dose form Count of base of active ingredient False 2 Inferred relationship Some
    Product containing only cocaine and epinephrine in ocular dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Some
    Hydrocortisone and pramocaine only product in cutaneous dose form Count of base of active ingredient False 2 Inferred relationship Some
    Hydroxyamfetamine and tropicamide only product in ocular dose form Count of base of active ingredient False 2 Inferred relationship Some
    Adrenaline and etidocaine only product in parenteral dose form Count of base of active ingredient False 2 Inferred relationship Some
    Codeine and kaolin only product in oral dose form Count of base of active ingredient False 2 Inferred relationship Some
    Adrenaline and mepivacaine only product in parenteral dose form Count of base of active ingredient False 2 Inferred relationship Some
    Adrenaline and bupivacaine only product in parenteral dose form Count of base of active ingredient False 2 Inferred relationship Some
    Ipratropium and salbutamol only product in pulmonary dose form Count of base of active ingredient False 2 Inferred relationship Some
    Esterified estrogen and methyltestosterone only product in oral dose form Count of base of active ingredient False 2 Inferred relationship Some

    Start Previous Page 22 of 24 Next End

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start